Scotland’s vaccination drive appears to be markedly reducing the risk of hospitalization for COVID-19, suggesting that both the Pfizer-BioNtech and Oxford-AstraZeneca shots are highly effective in preventing severe infections, preliminary study findings showed on Monday.
Results of the study, which covered the entire Scottish population of 5.4 million people, showed that by the fourth week after the initial dose, the Pfizer and AstraZeneca vaccines were found to reduce the risk of hospitalization by up to 85 per cent and 94 per cent respectively.
“These results are very encouraging and have given us great reasons to be optimistic for the future,” said Aziz Sheikh, a professor at the University of Edinburgh’s Usher Institute who co-led the study.
Sheik cautioned at a media briefing that the results are preliminary data, yet to be peer-reviewed by independent scientists, but added: “I am very encouraged. We now have national evidence … that vaccination provides protection against COVID-19 hospitalizations.”
He said he expected other countries using the same two vaccines and a similar strategy — such as England and Wales for example — would see a similar positive impact in reducing the number of people being hospitalized with COVID-19.
Data for the vaccines’ effect in Scotland was gathered between Dec. 8 and Feb. 15. Researchers said that during this period, 1.14 million vaccines were administered and 21 per cent of Scotland’s population had received a first dose.
Among those aged 80 years and over — one of the highest risk groups for COVID-19 — vaccination was associated with an 81 per cent reduction in hospitalization risk in the fourth week, when the results for both vaccines were combined.
Jim McMenamin, Public Health Scotland’s COVID-19 incident director, said the findings are particularly important “as we move from expectation to firm evidence of benefit from vaccines.”
Moderna says waiving IP rights won’t help increase vaccine supply
Canada allows Pfizer COVID-19 vaccine for children aged 12-15
(Corrects headline and lead to make clear that Canada was not the first nation as stated by Canadian officials, adds context from Pfizer in fourth paragraph)
By David Ljunggren
OTTAWA (Reuters) –Canada is authorizing the use of Pfizer Inc’s COVID-19 vaccine for use in children aged 12 to 15, the first doses to be allowed in the country for people that young, the federal health ministry said on Wednesday.
Supriya Sharma, a senior adviser at the Canadian federal health ministry, said the Pfizer vaccine, produced with German partner BioNTech SE, was safe and effective in the younger age group.
“We are starting to see the light at the end of the tunnel,” she told reporters.
Sharma and a health ministry spokesman said Canada was the first country to grant such an approval, but a Canadian representative for Pfizer later said Algeria permitted use of the vaccine for this age group in April. The Canadian health ministry said it had no information about the discrepancy.
The U.S. Food and Drug Administration is expected to take a similar step “very soon,” U.S. health officials said.
Separately, authorities reported the third death of a Canadian from a rare blood clot condition after receiving AstraZeneca PLC’s’s COVID-19 vaccine. The man, who was in his sixties, lived in the Atlantic province of New Brunswick.
Jennifer Russell, the chief medical officer of health in New Brunswick, said the province would continue using the AstraZeneca vaccine. Alberta reported a death from clotting on Tuesday and Quebec announced one on April 27.
“There will be rare cases where thrombosis will occur. However, the risks remain minimal compared to the risks, complications and potential consequences of COVID-19,” Russell told reporters.
Canada‘s federal government has bought tens of millions of doses of vaccines but critics complain the pace of inoculation is lagging due to bottlenecks in the 10 provinces, which are responsible for administering the doses.
Alberta will become the first province to offer COVID-19 vaccines to everyone aged 12 and over from May 10, Premier Jason Kenney said on Wednesday, a day after he introduced tighter public health measures to combat a third wave of the pandemic.
Alberta, home to Canada‘s oil patch, has the highest rate per capita of COVID-19 in the country, with nearly 24,000 active cases and 150 people in intensive care.
Around 20% of the 1,249,950 cases of COVID-19 in Canada have been reported in people under the age of 19. Canada has recorded 24,396 deaths.
(Additional reporting by Allison Martell in Toronto and Nia Williams in Calgary;Editing by Chizu Nomiyama and Sonya Hepinstall)
Younger people filling up COVID-19 intensive care
By Anthony Boadle
BRASILIA (Reuters) –COVID-19 infections continue to spread fast across the Americas as a result of relaxed prevention measures and intensive care units are filling up with younger people, the director of the Pan American Health Organization (PAHO) said on Wednesday.
In Brazil, mortality rates have doubled among those younger than 39, quadrupled among those in their 40s and tripled for those in their 50s since December, Carissa Etienne said.
Hospitalization rates among those under 39 years have increased by more than 70% in Chile and in some areas of the United States more people in their 20s are now being hospitalized for COVID-19 than people in their 70s.
“Despite all we learned about this virus in a year, our control efforts are not as strict, and prevention is not as efficient,” Etienne said in a virtual briefing from Washington.
“We are seeing what happens when these measures are relaxed: COVID spreads, cases mount, our health systems become overwhelmed and people die,” she said.
Canada continues to report significant jumps in infections in highly populated provinces such as Ontario as well as in less populated territories of the North and Yukon, home to remote and indigenous communities, according to PAHO.
Puerto Rico and Cuba remain significant drivers of COVID-19 cases in the Caribbean, which is facing a new surge of the virus, PAHO directors said.
Cases are rapidly accelerating in the Guyanas and across Argentina and Colombia, where weekly case counts are five times higher today than they were this time last year and hospitals are reaching capacity in large Colombian cities.
In Central America, Guatemala is seeing significant spikes in cases and Costa Rica is reporting record-high infections.
While vaccines are being rolled out as fast as possible, they are not a short-term solution because they are in short supply, said Etienne, the World Health Organization’s regional director.
(Reporting by Anthony Boadle; Editing by Nick Macfie)
AMC expects people to return to theaters as vaccine rollout gathers pace
Drugmakers say Biden misguided over vaccine patent waiver
Ashleigh Barty, Aryna Sabalenka to meet in Madrid final – WTA roundup
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Europe kicks off vaccination programs | All media content | DW | 27.12.2020 – Deutsche Welle
Business10 hours ago
Woodfibre LNG signs second BP deal for British Columbia LNG plant
Real eState10 hours ago
Canadian home prices, sales to moderate but remain high
Economy6 hours ago
Bank of England sees faster economic rebound
Economy5 hours ago
Bank of England line up to taper emergency stimulus
News10 hours ago
Alberta drops vaccine age to 12 as COVID-19 cases surge
Health4 hours ago
Moderna says waiving IP rights won’t help increase vaccine supply
News4 hours ago
Closer EU military cooperation with U.S., Canada, Norway is quantum leap, Germany says
News3 hours ago
EU supports COVID vaccine patent waiver talks, but critics say won’t solve scarcity